Search
Patexia Research
Case number 1:19-cv-01985

Par Pharmaceutical, Inc. et al v. Fresenius Kabi USA, LLC > Documents

Date Field Doc. No.Description (Pages)
Oct 1, 2020 N/A Terminated Case (0)
Docket Text: CASE CLOSED per the Signed Stipulation of Dismissal in Lead Case No. 18-2032-CFC. (nmf)
Jul 8, 2020 N/A CORRECTING ENTRY: (0)
Docket Text: CORRECTING ENTRY: D.I. Nos. 16-18 have been removed from this civil action as ALL FILINGS SHALL BE MADE IN LEAD CASE NO. 18-2032-CFC ONLY per the Order of Consolidation. (fms)
Jun 3, 2020 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Shaobo Zhu for Fresenius Kabi USA, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
Dec 9, 2019 N/A Create Case Association (0)
Docket Text: Case associated with lead case: Create association to 1:18-cv-02032-CFC. (fms)
Dec 9, 2019 N/A Remark (0)
Docket Text: ALL FILINGS GOING FORWARD SHALL BE FILED IN Civil Action No. l8-cv-2032-CFC. (fms)
Dec 9, 2019 15 SO ORDERED (4)
Docket Text: SO ORDERED, re (14 in 1:19-cv-01985-CFC) Stipulation and Order for Consolidation filed by Fresenius Kabi USA, LLC. Civil Action No. 19-cv-01985-CFC is consolidated with the other above described actions already consolidated under lead case Civil Action No. l8-cv-2032-CFC for all purposes, including trial, subject to further order of the Court. Civil Action No. l8-cv-2032-CFC shall remain the Lead Case and all filings going forward shall be filed in Civil Action No. l8-cv-2032-CFC. See Stipulation and Order for further details and deadlines. Signed by Judge Colm F. Connolly on 12/9/2019. Associated Cases: 1:19-cv-01985-CFC, 1:18-cv-02032-CFC(fms)
Dec 6, 2019 14 Stipulation (4)
Docket Text: STIPULATION and [Proposed] Order to Consolidate by Fresenius Kabi USA, LLC. (Vrana, Robert)
Nov 22, 2019 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney John T. Bennett for Fresenius Kabi USA, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d), Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (sam)
Nov 19, 2019 13 Answer to Counterclaim (16)
Docket Text: ANSWER to [7] Answer to Complaint, Counterclaim by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC.(Farnan, Kelly)
Nov 15, 2019 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Robert D. Rhoad for Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
Nov 13, 2019 12 Order (1)
Docket Text: ORDER, this case having been recently joined and ready for scheduling pursuant to Fed. R. Civ. P. 16 and as this case is listed as related to earlier filed cases that are currently proceeding on an agreed upon schedule entered by the Court; IT IS ORDERED that, on or before December 13, 2019, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: Notice of Compliance deadline set for 12/13/2019. Signed by Judge Colm F. Connolly on 11/13/2019. (nmf)
Nov 12, 2019 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [11] MOTION for Pro Hac Vice Appearance of Attorney Robert D. Rhoad and Sharon K. Gagliardi filed by Endo Par Innovation Company, LLC, Par Sterile Products, LLC, Par Pharmaceutical, Inc. Signed by Judge Colm F. Connolly on 11/12/2019. (fms)
Nov 11, 2019 11 Motion for Leave to Appear Pro Hac Vice (3)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Robert D. Rhoad and Sharon K. Gagliardi - filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Farnan, Kelly)
Nov 1, 2019 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [10] MOTION for Pro Hac Vice Appearance of Attorney Daryl L. Wiesen, John T. Bennett, Esquire and Shaobo Zhu, Esquire filed by Fresenius Kabi USA, LLC. Signed by Judge Colm F. Connolly on 11/1/2019. (fms)
Oct 31, 2019 10 Motion for Leave to Appear Pro Hac Vice (6)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Daryl L. Wiesen, John T. Bennett, Esquire and Shaobo Zhu, Esquire - filed by Fresenius Kabi USA, LLC. (Vrana, Robert)
Oct 29, 2019 N/A Add Corporate Affiliates/Parents (0)
Docket Text: Corporate Affiliates/Parents added per Disclosure Statement: identifying Corporate Parent Fresenius Kabi AG, Corporate Parent Fresenius SE & Co. KGaA for Fresenius Kabi USA, LLC. (fms)
Oct 29, 2019 7 Answer to Complaint (41)
Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC by Fresenius Kabi USA, LLC. (Attachments: # (1) Exhibit 1)(Gaza, Anne)
Oct 29, 2019 7 Exhibit 1 (34)
Oct 29, 2019 8 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,744,239 B2 . (Gaza, Anne)
Oct 29, 2019 9 Disclosure Statement (3)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Fresenius Kabi Pharmaceuticals Holding, Inc. for Fresenius Kabi USA, LLC filed by Fresenius Kabi USA, LLC. (Gaza, Anne)
Oct 23, 2019 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb)
Oct 22, 2019 6 Return of Service Executed (2)
Docket Text: Return of Service Executed by Par Pharmaceutical, Inc., Par Sterile Products, LLC, Endo Par Innovation Company, LLC. Fresenius Kabi USA, LLC served on 10/21/2019, answer due 11/12/2019. (Farnan, Kelly)
Oct 18, 2019 N/A Summons Issued (0)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Fresenius Kabi USA, LLC on 10/18/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg)
Oct 18, 2019 1 Exhibit A-E (387)
Oct 18, 2019 1 Civil Cover Sheet (1)
Oct 18, 2019 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg)
Oct 18, 2019 3 ANDA Form (2)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/9/2019. Date of Expiration of Patent: 1/30/2035.Thirty Month Stay Deadline: 3/9/2022. (nmg)
Oct 18, 2019 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,937,223 B2; 9,375,478 B1; 9,687,526 B2; 9,744,209 B2; 9,750,785 B2. (nmg)
Oct 18, 2019 5 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Endo International PLC for Par Pharmaceutical, Inc.; Corporate Parent Par Pharmaceutical, Inc. for Endo Par Innovation Company, LLC, Par Sterile Products, LLC filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (nmg)
Menu